Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Diagnostics firm rejects Escalon stock offer
London-The board of Drew Scientific Group PLC, a diagnostics company specializing in the design, manufacture, sale, and distribution of analytical systems for laboratory testing, has rejected Escalon Medical Corp.'s offer to trade its stock for Drew shares.
Related Videos
Related Content
